Risperidone versus haloperidol: II. Cost-effectiveness

This publication has 11 references indexed in Scilit:

• Reduction of Healthcare Resource Utilisation and Costs Following the Use of Risperidone for Patients with Schizophrenia Previously Treated with Standard Antipsychotic Therapy
  Clinical Drug Investigation, 1996
• Risperidone versus zuclopenthixol in the treatment of acute schizophrenic episodes: a double‐blind parallel‐group trial
  Acta Psychiatrica Scandinavica, 1995
• Decision Analytic Modeling: Some Uses in the Evaluation of New Pharmaceuticals
  Drug Information Journal, 1994
• Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations
  Acta Psychiatrica Scandinavica, 1993
• Economic Evaluation of Pharmaceuticals
  PharmacoEconomics, 1993
• Assessment of Costs and Benefits of Drug Therapy for Treatment-Resistant Schizophrenia in the United Kingdom
  The British Journal of Psychiatry, 1993
• Issues in the Cross-National Assessment of Health Technology
  International Journal of Technology Assessment in Health Care, 1992
• The Cost of Schizophrenia Revisited
  Schizophrenia Bulletin, 1991
• The Economic Costs of Schizophrenia
  Archives of General Psychiatry, 1985
• EPIDEMIOLOGY OF SCHIZOPHRENIA1
  Epidemiologic Reviews, 1985